INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 203 filers reported holding INARI MED INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,928,578 | -73.7% | 60,070 | -76.6% | 0.00% | -62.5% |
| Q2 2023 | $14,952,098 | +82.4% | 257,174 | +93.7% | 0.01% | +60.0% |
| Q1 2023 | $8,195,923 | +116.1% | 132,749 | +122.5% | 0.01% | +150.0% |
| Q4 2022 | $3,791,799 | +54.4% | 59,657 | +76.4% | 0.00% | +100.0% |
| Q3 2022 | $2,456,000 | -5.1% | 33,815 | -11.1% | 0.00% | 0.0% |
| Q2 2022 | $2,587,000 | -36.9% | 38,056 | -15.8% | 0.00% | -50.0% |
| Q1 2022 | $4,098,000 | -11.2% | 45,219 | -10.5% | 0.00% | 0.0% |
| Q4 2021 | $4,613,000 | -70.3% | 50,551 | -73.6% | 0.00% | -71.4% |
| Q3 2021 | $15,550,000 | -17.1% | 191,740 | -4.7% | 0.01% | -22.2% |
| Q2 2021 | $18,759,000 | +58.3% | 201,102 | +81.6% | 0.01% | +50.0% |
| Q1 2021 | $11,849,000 | +297.4% | 110,739 | +224.2% | 0.01% | +200.0% |
| Q4 2020 | $2,982,000 | +950.0% | 34,157 | +730.9% | 0.00% | – |
| Q3 2020 | $284,000 | – | 4,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |